![PDF) The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation PDF) The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation](https://i1.rgstatic.net/publication/344222157_The_transcriptional_repressor_Bcl6_promotes_pre-TCR_induced_differentiation_to_CD4CD8_thymocyte_and_attenuates_Notch1_activation/links/5f6a53f7458515b7cf46d55e/largepreview.png)
PDF) The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation
![PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling](https://i1.rgstatic.net/publication/369877133_Azacitidine_Is_Synergistically_Lethal_with_XPO1_Inhibitor_Selinexor_in_Acute_Myeloid_Leukemia_by_Targeting_XPO1eIF4Ec-MYC_Signaling/links/64305146ad9b6d17dc4115e1/largepreview.png)
PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
![PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling](https://www.researchgate.net/publication/369877133/figure/fig2/AS:11431281139772673@1680888153603/Transcriptome-analysis-to-identify-the-key-genes-and-pathways-responsible-for-the_Q320.jpg)
PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
![PDF) The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity PDF) The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity](https://i1.rgstatic.net/publication/329006716_The_sensitivity_to_Hsp90_inhibitors_of_both_normal_and_oncogenically_transformed_cells_is_determined_by_the_equilibrium_between_cellular_quiescence_and_activity/links/5c5d7e8e299bf1d14cb3ca3b/largepreview.png)
PDF) The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity
![PDF) The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation PDF) The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation](https://www.researchgate.net/publication/344222157/figure/fig4/AS:938653601783808@1600803866016/Bcl6-is-required-for-enrichment-of-icTCR-DN-cells-and-DN4-survival_Q320.jpg)
PDF) The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation
![PDF) Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2 PDF) Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2](https://www.researchgate.net/profile/David-Frank-10/publication/259770843/figure/fig1/AS:601649735294992@1520455883537/Inhibition-of-Brd2-reduces-STAT5-transcriptional-function-A-ALL-SIL-cells-were_Q320.jpg)
PDF) Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
![PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling](https://www.researchgate.net/publication/369877133/figure/fig4/AS:11431281139744180@1680888154071/Cont_Q320.jpg)
PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
![PDF) MEF2B mutations lead to deregulated expression of the BCL6 oncogene in Diffuse Large B cell Lymphoma PDF) MEF2B mutations lead to deregulated expression of the BCL6 oncogene in Diffuse Large B cell Lymphoma](https://i1.rgstatic.net/publication/256100894_MEF2B_mutations_lead_to_deregulated_expression_of_the_BCL6_oncogene_in_Diffuse_Large_B_cell_Lymphoma/links/0deec53c530523cce0000000/largepreview.png)
PDF) MEF2B mutations lead to deregulated expression of the BCL6 oncogene in Diffuse Large B cell Lymphoma
![PDF) Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway PDF) Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway](https://i1.rgstatic.net/publication/322848989_Metabolomic_Profiling_Reveals_Cellular_Reprogramming_of_B-Cell_Lymphoma_by_a_Lysine_Deacetylase_Inhibitor_through_the_Choline_Pathway/links/5a8b05000f7e9b1a9555a2b5/largepreview.png)
PDF) Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway
![PDF) Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2 PDF) Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2](https://www.researchgate.net/profile/David-Frank-10/publication/259770843/figure/fig2/AS:601649735299101@1520455883569/Brd2-inhibition-by-JQ1-or-shRNA-knockdown-does-not-affect-STAT5-phosphorylation-or-DNA_Q320.jpg)
PDF) Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
![PDF) Presence of Lamin A is Required for GATA3 and ERα Downregulation by Histone Deacetylase Inhibitor in Breast Cancer Cells PDF) Presence of Lamin A is Required for GATA3 and ERα Downregulation by Histone Deacetylase Inhibitor in Breast Cancer Cells](https://i1.rgstatic.net/publication/326786450_Presence_of_Lamin_A_is_Required_for_GATA3_and_ERa_Downregulation_by_Histone_Deacetylase_Inhibitor_in_Breast_Cancer_Cells/links/5b638612a6fdcc45b30c6a4e/largepreview.png)
PDF) Presence of Lamin A is Required for GATA3 and ERα Downregulation by Histone Deacetylase Inhibitor in Breast Cancer Cells
![Diversity-orientated synthesis of macrocyclic heterocycles using a double S N Ar approach - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D1OB00612F Diversity-orientated synthesis of macrocyclic heterocycles using a double S N Ar approach - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D1OB00612F](https://pubs.rsc.org/image/article/2021/OB/d1ob00612f/d1ob00612f-s4.gif)
Diversity-orientated synthesis of macrocyclic heterocycles using a double S N Ar approach - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D1OB00612F
![PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling PDF) Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling](https://www.researchgate.net/publication/369877133/figure/fig3/AS:11431281139724784@1680888153861/Effect-of-c-MYC-knockdown-on-the-combination-mediated-proliferation-in-U937-cells-A_Q320.jpg)